Follitropin Beta

CHEMBL5315126 Phase 4 Aprobado Protein

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

This biosynthetically produced follicle-stimulating hormone is used in fertility treatments to stimulate egg development in women undergoing assisted reproduction procedures. It is also used to stimulate sperm production in men with certain hormonal causes of infertility.

Áreas terapéuticas

Cáncer colorrectal Cáncer de mama Cáncer de ovario Cáncer de páncreas Cáncer de próstata Cáncer de pulmón de células no pequeñas Cáncer de tiroides Cáncer de vejiga Endometriosis Obesidad

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This biosynthetically produced follicle-stimulating hormone is used in fertility treatments to stimulate egg development in women undergoing assisted reproduction procedures. It is also used to stimulate sperm production in men with certain hormonal causes of infertility.

Yes, Follitropin Beta is an approved drug. It has reached clinical phase 4. It is classified as a Protein.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL5315126. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

¿Busca información accesible para el paciente?

Follitropin Beta en PillFYI

Datos Rápidos

Enlaces externos

ChEMBL CHEMBL5315126

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.